Does renal denervation provide durable and safe adjunctive therapy for uncontrolled hypertension?
Renal denervation is highlighted as a potentially durable and safe adjunctive therapy for uncontrolled hypertension, though long-term cardiovascular outcomes are still awaited.
These data support RDN as a potentially durable and safe adjunctive therapy for uncontrolled hypertension in appropriately selected patients. Benefits appear to extend to high-risk populations including patients with diabetes, chronic kidney disease, and prior stroke, though long-term cardiovascular outcome data remain awaited.
Stephan et al. (Tue,) studied this question.